These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 6141201

  • 1. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
    Macchia E, Fenzi GF, Monzani F, Bartalena L, Lippi F, Aloisio V, Cupini C, Baschieri L, Pinchera A.
    J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y, Ishihara T, Ikekubo K, Mori T.
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [Abstract] [Full Text] [Related]

  • 15. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy.
    Leövey A, Kálmán K, Szabó T, Lente K, Sándor P, Balázs C.
    Acta Med Acad Sci Hung; 1980 Feb; 37(4):345-50. PubMed ID: 6263033
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P, Rotella CM, Valente WA, Cohen J, Aloj SM, Laccetti P, Ambesi-Impiombato FS, Grollman EF, Pinchera A, Toccafondi R, Kohn LD.
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J, Trokoudes K, Silverberg J, Row V, Volpé R.
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [Abstract] [Full Text] [Related]

  • 18. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA, Valente WA, Ekins RP, Kohn LD, Marshall NJ.
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P, Adler G, Roulier R, Lissitzky S.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [Abstract] [Full Text] [Related]

  • 20. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
    Marcocci C, Valente WA, Pinchera A, Aloj SM, Kohn LD, Grollman EF.
    J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.